$XFOR SEC Filings

Filed On	Filing
19 Oct 2026	Form 4: Craig Adam R, Director Bought 4,600 shares ($11.9K)
08 Oct 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more - Strengthens Financial Flexibility with Access to Funding for Corporate and Commercial Activities -
07 Oct 2026	SCHEDULE 13G/A
05 Oct 2026	Form 4: Kirske David, Chief Financial Officer Sold 11,767 shares ($33.7K)
01 Oct 2026	144
21 Sep 2026	SCHEDULE 13G
09 Sep 2026	8-K: Other Events Corporate Presentation September 2026 Nasdaq: XFOR EXHIBIT 99.1
08 Sep 2026	8-K: Other Events - FDA Agrees to Reduced Sample Size for the Global 4WARD Phase 3 Chronic Neutropenia Trial -
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	Form 4: Volpone John, President Sold 24,576 shares ($109K)
13 Aug 2026	Form 4: Craig Adam R, Director Sold 47,436 shares ($211K)
13 Aug 2026	144
13 Aug 2026	144
06 Aug 2026	10-Q
30 Jul 2026	SCHEDULE 13G
01 Jul 2026	Form 4: Kirske David, Chief Financial Officer Sold 8,543 shares ($36.4K)
01 Jul 2026	Form 4: Gold Kelly, Director Granted 110,000 Stock Option (right to buy)
01 Jul 2026	Form 3: Gold Kelly, Director No securities owned
01 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Comments